Trial Profile
A prospective parallel, double-blinded, randomized study to evaluate pharmacokinetics of tenofovir emtricitabine in healthy women
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 11 Sep 2015
Price :
$35
*
At a glance
- Drugs Tenofovir (Primary) ; Emtricitabine
- Indications HIV infections
- Focus Pharmacokinetics
- 11 Sep 2015 New trial record
- 22 Jul 2015 Results presented at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention.